Answers are grounded in this paper and cite their sources.
The design of molecular switches for the production of responsive or “smart” imaging agents is a major challenge. Of particular interest are agents that respond to biological redox environment to map those disease states that involve redox imbalances.[1] Redox imbalances may be triggered in many ways, including very low oxygen pressure or hypoxia in the case of solid tumors.[2] Importantly, the development of probes to map oxygen levels and corresponding redox status of tumor tissue may guide the development of tumor-selective drugs.[3]
No takes yet. Share an insight, caveat, or question.
Tsitovich et al. (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: